Antiproliferative effect of Pygeum africanum extract on rat prostatic fibroblasts

Journal of Urology

Volumn 157, Issue 6, 1997, Pages 2381-2387

  Yablonsky, Françoise ^a   Nicolas, Véronique ^a   Riffaud, Jean Pierre ^a   Bellamy, Françoise ^a  

^a Laboratoires Debat   (France)

Author keywords

prostate; Pygeum africanum; rat; stromal cells

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; PLANT EXTRACT; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; DNA SYNTHESIS; FIBROBLAST; IMMUNOCYTOCHEMISTRY; MICTURITION DISORDER; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RAT;

PYGEUM AFRICANUM;

EID: 0030901813     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64785-2     Document Type: Article

References (42)

1. Barlet, A., Albrecht, J., Aubert, A., Fischer, M., Grof, F., Grothuesmann, H. G., Masson, J. C., Mazeman, E., Mermon, R., Reichelt, H., Schönmetzler, H. G. and Suhler, A.: Efficacy of Pygeum africanum extract in the treatment of micturitional disorders due to benign prostatic hyperplasia. Evaluation of objective and subjective parameters. A multicenter, randomized, double-blind trial. Wien. Klin. Wochenschr., 22: 667, 1990.
2. Marconi, M., D'Angelo, L., Del Vecchio, A., Caravaggi, M., Lecchini, S., Frigo, G. M. and Crema, A.: Anti-inflammatory action of Pygeum africanum extract in the rat. Farmaci. & Terapia., 3: 135, 1986.
3. Riffaud, J. P. and Lacolle, J. Y.: Effects of Tadenan® on the detrusor smooth muscle of young and old rats. Eur. Urol., 18: 309, 1990.
4. Levin, R. M., Riffaud, J. P., Bellamy, F., Rohrmann, D., Habi, M., Krasnopolsky, L., Zhao, Y. and Wein, A. J.: Protective effect of Tadenan on bladder function secondary to partial outlet obstruction. J. Urol., 155: 1466, 1996.
5. ®), a 5α reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5α reductase inhibition. Prostate, 22: 43, 1993.
6. Desgrandchamps, F. and Teillac, P.: The role of growth factors in the pathogenesis of benign prostatic hyperplasia. Biomed. Pharmacother., 48: 19s, 1994.
7. Steiner, M. S.: Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J. Urol., 153: 1085, 1995.
8. Byrne, R. L., Leung, H. and Neal, D. E.: Peptide growth factors in the prostate as mediators of stromal epithelial interaction. Br. J. Urol., 77: 627, 1996.
9. Culig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Hittmair, A., Zhang, J., Thurnher, M., Bartsch, G. and Klocker, H.: Regulation of prostatic growth and function by peptide growth factors. Prostate, 28: 392, 1996.
10. Tenniswood, M.: Role of epithelial-stromal interactions in the control of gene expression in the prostate: an hypothesis. Prostate, 9: 375, 1986.
11. Nishi, N., Matuo, Y., Muguruma, Y., Yoshitake, Y., Nishikawa, K. and Wada, F.: A human prostatic growth factor (hPGF): partial purification and characterization. Biochem. Biophys. Res. Commun., 132: 1103, 1985.
12. Nishi, N., Matuo, Y., Kunitomi, K., Takenaka, I., Usami, M., Kotake, T. and Wada, F.: Comparative analysis of growth factors in normal and pathologic human prostates. Prostate, 13: 38, 1988.
13. Mori, H., Maki, M., Oishi, K., Jaye, M., Igarashi, K., Yoshida, O. and Hatanaka, M.: Increased expression of genes for basic fibroblast growth factor and transforming growth factor type β2 in human benign prostatic hyperplasia. Prostate, 16: 71, 1990.
14. Sherwood, E. R., Fong, C., Lee, C. and Koslowsky, J. M.: Basic fibroblast growth factor: a potential mediator of stromal growth in the human prostate. Endocrinology, 130: 2955, 1992.
15. Habib, F. K.: Peptide growth factors: a new frontier in prostate cancer. Prog. Clin. Biol. Res., 357: 107, 1990.
16. Fiorelli, G., De Bellis, A., Longo, A., Pioli, P., Costantini, A., Giannini, S., Forti, G. and Serio, M.: Growth factors in the human prostate. J. Steroid. Biochem. Molec. Biol., 40: 199, 1991.
17. Hiramatsu, M., Kashimata, M., Minami, N., Sato, A., Murayama, M. and Minami, N.: Androgenic regulation of epidermal growth factor in the mouse ventral prostate. Biochem. Int., 17: 311, 1988.
18. Barni, T., Vannelli, B. G., Sadri, R., Pupilli, C., Ghiandi, P., Rizzo, M., Selli, C., Serio, M. and Fiorelli, G.: Insulin-like growth factor-I (IGF-I) and its binding protein IGFBP-4 in human prostatic hyperplastic tissue: gene expression and its cellular localization. J. Clin. Endocrinol. Metab., 78: 778, 1994.
19. Cohen, D. W., Simak, R., Fair, W. R., Melamed, J., Scher, H. I. and Cordon-Cardo, C.: Expression of transforming growth factor-α and the epidermal growth factor receptor in human prostate tissues. J. Urol., 152: 2120, 1994.
20. Finch, P. W., Rubin, J. S., Miki, T., Ron, D. and Aaronson, S. A.: Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science, 245: 752, 1989.
21. Paubert-Braquet, M., Monboisse, J. C., Servent-Saez, N., Serikoff, A., Cavé, A., Hocquemiller, R., Dupont, C., Fourneau, C. and Borel, J. P.: Inhibition of bFGF and EGF-induced proliferation of 3T3 fibroblasts by extract of Pygeum africanum (Tadenan®). Biomed. Pharmacother., 48: 43s, 1994.
22. Cussenot, O., Berthon, P., Cochand-Priollet, B., Maitland, N. J. and Le Due, A.: Immunocytochemical comparison of cultured normal epithelial prostatic cells with prostatic tissue sections. Exp. Cell. Res., 214: 83, 1994.
23. Begun, F. P., Story, M. T., Hopp, K. A., Shapiro, E. and Lawson, R. K.: Regional concentration of basic fibroblast growth factor in normal and benign hyperplastic human prostates. J. Urol., 153: 839, 1995.
24. Story, M. T., Hopp, K. A., Meier, D. A., Begun, F. P. and Lawson, R. K: Influence of transforming growth factor β1 and other growth factors on basic fibroblast growth factor level and proliferation on cultured human prostate-derived fibroblasts. Prostate, 22: 183, 1993.
25. Levine, A. C., Ren, M., Huber, G. K. and Kirschenbaum, A.: The effect of androgen, estrogen, and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates. Endocrinology, 130: 2413, 1992.
26. Story, M. T., Hopp, K. A., Molter, M. and Meier, D.: Characteristics of FGF-receptors expressed by stromal and epithelial cells cultured from normal and hyperplastic prostates. Growth Factors, 10: 269, 1994.
27. Peterson, G. and Barnes, S.: Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate, 22: 335, 1993.
28. Reiter, E., Bonnet, P., Sente, B., Dombrowicz, D., de Leval, J., Closset, J. and Hennen, G.: Growth hormone and prolactin stimulate androgen receptor, insulin-like growth factor-I (IGF-I) and IGF-I receptor levels in the prostate of immature rats. Mol. Cell. Endocrinol., 88: 77, 1992.
29. Bonnet, P., Reiter, E., Bruyninx, M., Sente, B., Dombrowicz, D., de Leval, J., Closset, J. and Hennen, G.: Benign prostatic hyperplasia and normal prostate aging: difference in types I and II 5α-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J. Clin. Endocrinol. Metab., 77: 1203, 1993.
30. Kariya, K., Fukumoto, Y., Tsuda, T., Kawahara, M., Fukuzaki, H., Yamamoto, T. and Takai, Y.: Inhibition of DNA synthesis by phorbol esters through protein kinase C in cultured rabbit aortic smooth muscle cells. FEBS Lett., 217: 69, 1987.
31. Story, M. T., Livingston, B., Baeten, L., Swartz, S. J., Jacobs, S. C., Begun, F. P. and Lawson, R. K.: Cultured human prostate-derived fibroblasts produce a factor that stimulate their growth with properties indistinguishable from basic fibroblast growth factor. Prostate, 15: 355, 1989.
32. Jacobs, S. C., Story, M. T., Sasse, J. and Lawson, R. K.: Characterization of growth factors derived from the rat ventral prostate. J. Urol., 139: 1106, 1988.
33. Story, M. T.: Positive and negative modulators of prostate cell proliferation. Biomed. Pharmacother., 48: 35s, 1994.
34. Chen, W. S., Lazar, C. S., Poeni, M., Tsien, R. Y., Gill, G. N. and Rosenfield, M. G.: Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor. Nature, 328: 820, 1987.
35. Jaye, M., Schlessinger and Dionne, C. A.: Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim. Biophys. Acta, 1135: 185, 1992.
36. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, S., Watanabe, S., Itoh, N., Shiyuba, M. and Fukiyama, Y.: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262: 5592, 1987.
37. Linassier, C., Pierre, M., Le Pecq, J. B. and Pierre, J.: Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem. Pharmacol., 39: 187, 1989.
38. Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G., Hase, T., Montesano, R. and Schweigerer, L.: Genistein, a dietery-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA, 90: 2690, 1993.
39. Collins, M. and Rozengurt, E.: Binding of phorbol esters to high affinity sites on murine fibroblastic cells elicits a mitogenic response. J. Cell. Physiol., 112: 42, 1982.
40. Clemens, M. J., Trayner, I. and Menaya, J.: The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. J. Cell. Sci., 103: 881, 1992.
41. Kaibuchi, K., Tsuda, T., Kikuchi, A., Tanimoto, T., Yamashita, T. and Takai, Y.: Possible involvement of protein kinase C and calcium ion in growth factor-induced expression of c-myc oncogene in Swiss 3T3 fibroblasts. J. Biol. Chem., 261: 1187, 1986.
42. Kikkawa, U., Takai, Y., Tanaka, Y., Miyake, R. and Nishizuka, Y.: Protein kinase C as a possible receptor protein of tumor-promoting phorbol esters. J. Biol. Chem., 258: 11442, 1983.